<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Viruses</journal-id><journal-id journal-id-type="publisher-id">viruses</journal-id><journal-title-group><journal-title>Viruses</journal-title></journal-title-group><issn pub-type="epub">1999-4915</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40007038</article-id><article-id pub-id-type="pmc">PMC11860355</article-id><article-id pub-id-type="doi">10.3390/v17020283</article-id><article-id pub-id-type="publisher-id">viruses-17-00283</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The Deletion of the MGF360-10L/505-7R Genes of African Swine Fever Virus Results in High Attenuation but No Protection Against Homologous Challenge in Pigs</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0001-7964-652X</contrib-id><name><surname>Zheng</surname><given-names>Linlin</given-names></name><xref rid="af1-viruses-17-00283" ref-type="aff">1</xref><xref rid="af2-viruses-17-00283" ref-type="aff">2</xref><xref rid="af3-viruses-17-00283" ref-type="aff">3</xref><xref rid="fn1-viruses-17-00283" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Zilong</given-names></name><xref rid="af4-viruses-17-00283" ref-type="aff">4</xref><xref rid="fn1-viruses-17-00283" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Qi</surname><given-names>Xiaolan</given-names></name><xref rid="af1-viruses-17-00283" ref-type="aff">1</xref><xref rid="af3-viruses-17-00283" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Ren</surname><given-names>Jingjing</given-names></name><xref rid="af1-viruses-17-00283" ref-type="aff">1</xref><xref rid="af3-viruses-17-00283" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Zhao</given-names></name><xref rid="af5-viruses-17-00283" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Huanan</given-names></name><xref rid="af1-viruses-17-00283" ref-type="aff">1</xref><xref rid="af3-viruses-17-00283" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Zhao</given-names></name><xref rid="af1-viruses-17-00283" ref-type="aff">1</xref><xref rid="af3-viruses-17-00283" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Dan</given-names></name><xref rid="af1-viruses-17-00283" ref-type="aff">1</xref><xref rid="af3-viruses-17-00283" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3979-8991</contrib-id><name><surname>Pei</surname><given-names>Jingjing</given-names></name><xref rid="af1-viruses-17-00283" ref-type="aff">1</xref><xref rid="af3-viruses-17-00283" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Xiao</surname><given-names>Shuqi</given-names></name><xref rid="af1-viruses-17-00283" ref-type="aff">1</xref><xref rid="af3-viruses-17-00283" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7824-7298</contrib-id><name><surname>Feng</surname><given-names>Tao</given-names></name><xref rid="af1-viruses-17-00283" ref-type="aff">1</xref><xref rid="af3-viruses-17-00283" ref-type="aff">3</xref><xref rid="c1-viruses-17-00283" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xinglong</given-names></name><xref rid="af2-viruses-17-00283" ref-type="aff">2</xref><xref rid="c1-viruses-17-00283" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Haixue</given-names></name><xref rid="af1-viruses-17-00283" ref-type="aff">1</xref><xref rid="af3-viruses-17-00283" ref-type="aff">3</xref><xref rid="c1-viruses-17-00283" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Qiu</surname><given-names>Hua-Ji</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-viruses-17-00283"><label>1</label>State Key Laboratory for Animal Disease Control and Prevention, Lanzhou Veterinary Research Institute, College of Veterinary Medicine, Lanzhou University, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China; <email>linlinzheng0605@163.com</email> (L.Z.); <email>qixiaolan@caas.cn</email> (X.Q.); <email>renjingjing@caas.cn</email> (J.R.); <email>liuhuanan2008@163.com</email> (H.L.); <email>zzhao0829@163.com</email> (Z.Z.); <email>lidan@caas.cn</email> (D.L.); <email>jpei@caas.cn</email> (J.P.); <email>shqxiaojd@126.com</email> (S.X.)</aff><aff id="af2-viruses-17-00283"><label>2</label>College of Veterinary Medicine, Northwest A&#x00026;F University, Yangling 712199, China</aff><aff id="af3-viruses-17-00283"><label>3</label>Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou 730046, China</aff><aff id="af4-viruses-17-00283"><label>4</label>College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China; <email>zilong00scau@163.com</email></aff><aff id="af5-viruses-17-00283"><label>5</label>State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China; <email>mazhaomz@foxmail.com</email></aff><author-notes><corresp id="c1-viruses-17-00283"><label>*</label>Correspondence: <email>fengtao@caas.cn</email> (T.F.); <email>wxlong@nwsuaf.edu.cn</email> (X.W.); <email>haixuezheng@163.com</email> (H.Z.)</corresp><fn id="fn1-viruses-17-00283"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>18</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>17</volume><issue>2</issue><elocation-id>283</elocation-id><history><date date-type="received"><day>24</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>12</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>15</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>African swine fever virus (ASFV) is the causative agent of African swine fever (ASF), a severe hemorrhagic disease with a mortality rate reaching 100%. Despite extensive research on ASFV mechanisms, no safe and effective vaccines or antiviral treatments have been developed. Live attenuated vaccines generated via gene deletion are considered to be highly promising. We developed a novel recombinant ASFV strain by deleting <italic toggle="yes">MGF360-10L</italic> and <italic toggle="yes">MGF505-7R</italic>, significantly reducing virulence in pigs. In the inoculation experiment, pigs were infected with 10<sup>4</sup> 50% hemadsorption doses (HAD<sub>50</sub>) of the mutant strain. All the animals survived the observation period without showing ASF-related clinical signs. Importantly, no significant viral infections were detected in the cohabitating pigs. In the virus challenge experiment, all pigs succumbed after being challenged with the parent strain. RNA-seq analysis showed that the recombinant virus induced slightly higher expression of natural immune factors than the parent ASFV; however, this level was insufficient to provide immune protection. In conclusion, our study demonstrates that deleting <italic toggle="yes">MGF360-10L</italic> and <italic toggle="yes">MGF505-7R</italic> from ASFV CN/GS/2018 significantly reduces virulence but fails to provide protection against the parent strain.</p></abstract><kwd-group><kwd>ASFV</kwd><kwd>MGF360-10L</kwd><kwd>MGF505-7R</kwd><kwd>attenuated strain</kwd><kwd>immunoprotection</kwd></kwd-group><funding-group><award-group><funding-source>the open competition program of the top ten critical priorities of Agricultural Science and Technology Innovation for the 14th Five-Year Plan of Guangdong Province</funding-source><award-id>2024KJ14</award-id></award-group><award-group><funding-source>National Natural Science Foundation of China (NSFC)</funding-source><award-id>32302855</award-id></award-group><award-group><funding-source>STI 2030-Major Projects</funding-source><award-id>2023ZD0404301</award-id></award-group><award-group><funding-source>the Joint Scientific Research Foundation of Gansu province</funding-source><award-id>23JRRA1478</award-id></award-group><award-group><funding-source>the Fundamental Research Funds for the Central Universities</funding-source><award-id>20230904</award-id></award-group><award-group><funding-source>the Gansu province&#x02019;s key talents program</funding-source><award-id>212068657016</award-id></award-group><award-group><funding-source>the Gansu province&#x02019;s longyuan young talents</funding-source><award-id>20230102</award-id></award-group><award-group><funding-source>the Innovation Program of Chinese Academy of Agricultural Sciences</funding-source><award-id>CAAS-ASTIP-2021-LVRI, CAAS-CSLPDCP-2023002, CAAS-CSAB-202401</award-id></award-group><award-group><funding-source>the Natural Science Foundation of Gansu province</funding-source><award-id>23JRRA556</award-id></award-group><award-group><funding-source>the China Postdoctoral Science Foundation</funding-source><award-id>2023M733818</award-id></award-group><funding-statement>This study was supported by grants from the open competition program of the top ten critical priorities of Agricultural Science and Technology Innovation for the 14th Five-Year Plan of Guangdong Province (2024KJ14), the National Natural Science Foundation of China (NSFC) (32302855), STI 2030-Major Projects (2023ZD0404301), the Joint Scientific Research Foundation of Gansu province (23JRRA1478), the Fundamental Research Funds for the Central Universities (20230904), the Gansu province&#x02019;s key talents program (212068657016), the Gansu province&#x02019;s longyuan young talents program (20230102), the Innovation Program of Chinese Academy of Agricultural Sciences (CAAS-ASTIP-2021-LVRI, CAAS-CSLPDCP-2023002, CAAS-CSAB-202401), the Natural Science Foundation of Gansu province (23JRRA556), and the China Postdoctoral Science Foundation (2023M733818).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-viruses-17-00283"><title>1. Introduction</title><p>African swine fever (ASF) is a highly contagious and fatal disease caused by African swine fever virus (ASFV) and characterized by fever and hemorrhaging in all organs of pigs. The mortality rate in pigs can reach 100% [<xref rid="B1-viruses-17-00283" ref-type="bibr">1</xref>,<xref rid="B2-viruses-17-00283" ref-type="bibr">2</xref>] and clinical manifestations resemble those of classical swine fever, including lethargy, loss of appetite, high fever, cyanosis, abortion, edema, hemorrhaging, and ataxia. ASFV also causes immune system disorders in infected animals [<xref rid="B3-viruses-17-00283" ref-type="bibr">3</xref>]. ASFV was first reported in Kenya in 1921 and later spread widely among domestic pigs and wild boars across many countries south of the Sahara [<xref rid="B4-viruses-17-00283" ref-type="bibr">4</xref>]. Since 2007, ASFV has spread widely in eastern Europe following its introduction into Georgia [<xref rid="B5-viruses-17-00283" ref-type="bibr">5</xref>]. In 2018, Rongliang Hu reported the first case of ASF in China [<xref rid="B6-viruses-17-00283" ref-type="bibr">6</xref>], and, since then, the epidemic has rapidly spread across the country, threatening the pig farming industry and causing significant economic losses. ASF poses a significant threat to the pig farming industry both in China and worldwide. Currently, no safe and effective vaccine exists, and the epidemic can only be controlled through culling, which not only causes significant economic losses but also causes a failure to meet the needs of large-scale pig farming worldwide [<xref rid="B7-viruses-17-00283" ref-type="bibr">7</xref>,<xref rid="B8-viruses-17-00283" ref-type="bibr">8</xref>]. Therefore, vaccines, the most effective and economical means of preventing viral infections, are crucial for controlling ASF in pig farming systems.</p><p>ASFV is the only known DNA arbovirus and the sole member of the <italic toggle="yes">Asfarviridae</italic> family [<xref rid="B9-viruses-17-00283" ref-type="bibr">9</xref>,<xref rid="B10-viruses-17-00283" ref-type="bibr">10</xref>,<xref rid="B11-viruses-17-00283" ref-type="bibr">11</xref>]. The average diameter of ASFV is 260&#x02013;300 nm, with a genome size ranging from 170 to 194 kb [<xref rid="B11-viruses-17-00283" ref-type="bibr">11</xref>,<xref rid="B12-viruses-17-00283" ref-type="bibr">12</xref>]. Structural analysis of ASFV reveals that the viral particle consists of five layers: the outer membrane, the viral capsid, the inner membrane, the nucleocapsid, and the DNA genome [<xref rid="B13-viruses-17-00283" ref-type="bibr">13</xref>,<xref rid="B14-viruses-17-00283" ref-type="bibr">14</xref>,<xref rid="B15-viruses-17-00283" ref-type="bibr">15</xref>,<xref rid="B16-viruses-17-00283" ref-type="bibr">16</xref>]. ASFV has a complex structure and a large genome, though most of its functions remain unidentified. The mechanisms underlying ASFV infection and pathogenesis are poorly understood, and the theoretical framework for vaccine development remains limited. Therefore, a promising strategy is to identify virulence genes and develop attenuated ASFV strains. Despite the existence of several attenuated vaccine patents, their safety and efficacy still require further validation.</p><p>The development of ASFV vaccines currently involves three main approaches: inactivated vaccines, subunit and live vector vaccines, and recombinant virus vaccines. Among these, inactivated vaccines fail to provide effective immune protection in pigs [<xref rid="B17-viruses-17-00283" ref-type="bibr">17</xref>,<xref rid="B18-viruses-17-00283" ref-type="bibr">18</xref>], while subunit and live vector vaccines are insufficient to induce robust immunity [<xref rid="B19-viruses-17-00283" ref-type="bibr">19</xref>,<xref rid="B20-viruses-17-00283" ref-type="bibr">20</xref>,<xref rid="B21-viruses-17-00283" ref-type="bibr">21</xref>,<xref rid="B22-viruses-17-00283" ref-type="bibr">22</xref>,<xref rid="B23-viruses-17-00283" ref-type="bibr">23</xref>,<xref rid="B24-viruses-17-00283" ref-type="bibr">24</xref>]. The most promising approach is the gene knockout vaccine, which involves deleting immunosuppressive, tolerance, and ADE-related toxicity genes. This results in vaccine candidates that are both immunogenic and less pathogenic, providing immune protection to pigs.</p><p>The deletion of virulence genes is a strategy for constructing attenuated ASFV, and selecting appropriate genes for co-deletion is also critical. Not all combinations of virulence genes lead to effective attenuation and protection. The ASFV genome contains five members of the multigene family (MGF) that have evolved through gene duplication [<xref rid="B25-viruses-17-00283" ref-type="bibr">25</xref>]. The co-deletion of MGF505/530 family genes and MGF360 family genes has been shown to provide some degree of attenuation and protection [<xref rid="B26-viruses-17-00283" ref-type="bibr">26</xref>]. The deletion of <italic toggle="yes">CD2v</italic>, combined with all MGF360/505 genes, leads to attenuated strains that provide partial immune protection [<xref rid="B27-viruses-17-00283" ref-type="bibr">27</xref>], although the virus can still be detected in the serum of immunized pigs. Similarly, the deletion of <italic toggle="yes">MGF360-10L</italic>, <italic toggle="yes">-11L</italic>, <italic toggle="yes">-12L</italic>, <italic toggle="yes">-13L</italic>, and <italic toggle="yes">-14L</italic> along with <italic toggle="yes">MGF505-1R</italic>, <italic toggle="yes">-2R</italic>, and <italic toggle="yes">-3R</italic> from the virulent type II Georgia 2007/1 isolate reduces viral replication in pig macrophages but only provides 25% protection [<xref rid="B28-viruses-17-00283" ref-type="bibr">28</xref>]. Furthermore, the joint deletion of <italic toggle="yes">MGF360-12L</italic>, <italic toggle="yes">MGF505-1R</italic>, and <italic toggle="yes">K145R</italic> significantly reduces viral infection in pigs, but only 30% of immunized pigs were protected [<xref rid="B28-viruses-17-00283" ref-type="bibr">28</xref>]. In summary, these deletion strains still present safety and efficacy concerns.</p><p>In this study, we developed a safer attenuated ASFV strain by deleting <italic toggle="yes">MGF360-10L</italic> and <italic toggle="yes">MGF505-7R</italic> genes. In a high-dose inoculation experiment (104 HAD50), pigs (<italic toggle="yes">n</italic> = 9) showed no signs of disease, indicating that the virus strain did not cause illness or death. Importantly, no significant viremia or ASFV p30-specific antibody response was detected in cohabitating pigs. However, the attenuated virus strain did not confer protection against the high-pathogenic ASFV CN/GS/2018 strain.</p></sec><sec id="sec2-viruses-17-00283"><title>2. Materials and Methods</title><sec id="sec2dot1-viruses-17-00283"><title>2.1. Ethics Statements and Safety Protocols</title><p>This study was conducted following the guidelines in the Guide for the Care and Use of Laboratory Animals issued by the Ministry of Science and Technology, People&#x02019;s Republic of China. All animal experiments with ASFV CN/GS/2018 and ASFV-&#x00394;MGF360-10L/&#x00394;505-7R (ASFV-&#x00394;10L/&#x00394;7R) infections were carried out in biosafety-level-3 (P3) facilities at the Lanzhou Veterinary Research Institute (LVRI), Chinese Academy of Agricultural Sciences (CAAS), and approved by the Ministry of Agriculture and Rural Affairs and China National Accreditation Service for Conformity Assessment(permit no. LVRIAEC-2022-024) and date of approval is 28 October 2022.</p></sec><sec id="sec2dot2-viruses-17-00283"><title>2.2. Cells</title><p>The porcine bone marrow-derived macrophages (BMDMs) cell culture was prepared in-house. The protocol was slightly modified from a previously described method [<xref rid="B29-viruses-17-00283" ref-type="bibr">29</xref>]. In brief, porcine bone marrow cells were collected from 6~8-week-old piglets that were a commercial hybrid of Duroc &#x000d7; Large White &#x000d7; Landrace with an average weight of 30&#x02013;40 kg. By using grinding, filtration, washing, and Ficoll density centrifugation, cells were cultured in RPMI 1640 medium (20% FBS, 2% PSN; Thermo Fisher, Waltham, MA, USA) supplemented with 10 ng/mL recombinant porcine granulocyte-macrophage colony-stimulating factor (GM-CSF) (Kingfisher; Beijing, China) to differentiate them into macrophages. After 7 days of differentiation, mature BMDMs were frozen in 90% fetal bovine serum (FBS; CELL-BOX, Changsha, China) and 10% dimethyl sulfoxide (DMSO; Solarbio, Beijing, China) and stored in liquid nitrogen until further use. All cells were incubated at 37 &#x000b0;C with 5% CO<sub>2</sub>.</p></sec><sec id="sec2dot3-viruses-17-00283"><title>2.3. Viruses and Infection</title><p>ASFV strain CN/GS/2018 and the recombinant ASFV-&#x00394;10L/&#x00394;7R were characterized and stored in our laboratory. The virus was propagated in BMDM cells and the supernatants from the infected cells were clarified and stored at &#x02212;80 &#x000b0;C.</p><p><italic toggle="yes">For viral infection:</italic> Cells were cultured to approximately 80% confluence and infected with ASFV at a specific MOI, as per the experimental design. A mock infection was conducted using phosphate-buffered saline (PBS; Solarbio, Beijing, China). After 2 h of adsorption, the inoculum was removed by aspiration and the cells were washed twice with PBS before incubation in complete medium at 37 &#x000b0;C for various time points until harvesting.</p><p><italic toggle="yes">For the HAD<sub>50</sub> assay:</italic> The HAD<sub>50</sub> assay was used to quantify the median tissue culture infectivity of ASFV-WT- and ASFV-&#x00394;10L/&#x00394;7R-infected samples, as described previously, with minor modifications [<xref rid="B30-viruses-17-00283" ref-type="bibr">30</xref>]. Briefly, BMDM cells were seeded in 96-well plates for 2 h and 10-fold serially diluted samples were added to each well in triplicate. Next, the cells were incubated with 2% porcine red blood cells diluted in PBS and the hemadsorption (HAD) phenomenon was observed for 5 to 7&#x02009;days. Finally, HAD<sub>50</sub> was calculated using the Reed and Muench method [<xref rid="B31-viruses-17-00283" ref-type="bibr">31</xref>].</p></sec><sec id="sec2dot4-viruses-17-00283"><title>2.4. Antibodies</title><p>Primary antibody against GAPDH (Beyotime, Shanghai, China) was purchased from Beyotime. The antibodies against p72, p54, and p30 were derived from our laboratory.</p></sec><sec id="sec2dot5-viruses-17-00283"><title>2.5. Generation of MGF360-10L/MGF505-7R-Deficient Virus</title><p>The gene-deleted ASFV-&#x00394;10L/&#x00394;7R mutant was generated by two homologous recombinations of the genome of the parent ASFV CN/GS/2018 isolate with the recombinant transfer vector through transfection and infection procedures. Firstly, the <italic toggle="yes">MGF360-10L</italic> gene in the 1038 bp region was replaced by the reporter gene cassette p72eGFP containing 917 bp, and the obtained recombinant ASFV-&#x00394;MGF360-10L mutant underwent a second recombinant mutation after a series of limited dilution purifications on a monolayer BMDM culture. Similarly, a reporter gene cassette encompassing 908 bp p72mCherry was used to replace the <italic toggle="yes">MGF505-7R</italic> gene in the 1584 bp region and the resulting virus was purified by the continuous selection of fluorescent plaques bound to a limited dilution on a single layer of BMDM. Finally, a double-gene deletion recombinant ASFV-&#x00394;10L/&#x00394;7R mutant expressing eGFP/mCherry signal was obtained. In order to ensure the purity and correct deletion of the recombinant genome, DNA was extracted from the virus stock for PCR analysis. The detailed sequence of primer pairs is shown in <xref rid="viruses-17-00283-t001" ref-type="table">Table 1</xref>. After the mutated virus was purified, we amplified the virus three times to obtain virus stock (~80 mL), which was aliquoted and frozen in &#x02212;80 &#x000b0;C freezer.</p></sec><sec id="sec2dot6-viruses-17-00283"><title>2.6. Whole-Genome Sequencing</title><p>The CTAB/SDS method was employed to extract genomic DNA from ASFV strains. DNA concentration and purity were assessed using 1% agarose gel. Genomic DNA was digested with restriction enzymes to create fragments. Barcode ligation was performed on the fragments to prepare for sequencing. The DNA fragments were used to create a sequencing library via PCR amplification. Paired-end sequencing (PE150 mode) was performed on the Illumina HiSeq platform and data analysis was performed according to previously established protocols (34).</p></sec><sec id="sec2dot7-viruses-17-00283"><title>2.7. qPCR</title><p>After infection, we purified total DNA using the E.Z.N.A. Viral DNA Kit (OMEGA, Norcross, GA, USA) following the manufacturer&#x02019;s instructions. We then performed the TaqMan quantitative PCR assay with the Pro Taq HS Premix Probe qPCR Kit (ACCURATE BIOLOGY AG, Changsha, China) to quantify the virus genome copies. The primers and probes targeting the p72 gene are listed in <xref rid="viruses-17-00283-t001" ref-type="table">Table 1</xref>. Each 25 &#x003bc;L reaction consisted of 12.5 &#x003bc;L of 2&#x000d7; mix buffer, 3 &#x003bc;L of the standard plasmid/DNA template, 6.5 &#x003bc;L of H<sub>2</sub>O, and 3 &#x003bc;L of the p72 TaqMan probe. The qPCR was conducted using Applied Biosystems QuantStudio 5 as follows: enzyme activation at 95 &#x000b0;C for 2 min (1 cycle) followed by denaturation at 95 &#x000b0;C for 7 s and annealing at 60 &#x000b0;C for 12 s (3 cycles). Finally, denaturation occurred at 95 &#x000b0;C for 6 s and annealing at 58 &#x000b0;C for 11 s (40 cycles). We prepared the standard curve by diluting the standard plasmid ASFV p72 with a known copy number into different gradients. The diluted standard plasmid was incorporated into each of the 24 reactions, with 3 replicates for each sample. The final ASFV genome copy number was analyzed using QuantStudio&#x02122; Design &#x00026; Analysis Software v.1.3.1(&#x000a9;2016 Thermo Fisher Scientific, Waltham, MA, USA).</p></sec><sec id="sec2dot8-viruses-17-00283"><title>2.8. Real-Time PCR (RT-PCR)</title><p>Total RNA was extracted from ASFV-infected cells using TRIzol (Vazyme, Nanjing, China) and then the RNA was reverse-transcribed into cDNA utilizing a reverse transcription kit (Takara, Osaka, Osaka Prefecture, Japan). Finally, according to the instructions of TB Green dye standard quantitative kit (Takara, Osaka, Osaka Prefecture, Japan), qRT-PCR was used to detect mRNA levels of genes. The expression levels of genes were standardized by GAPDH and the relative mRNA expression levels of target genes were evaluated and calculated by the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method. All quantitative primers used in the qRT-PCR assay are shown in <xref rid="viruses-17-00283-t001" ref-type="table">Table 1</xref>.</p></sec><sec id="sec2dot9-viruses-17-00283"><title>2.9. Immunoblotting Assay</title><p>BMDMs were infected with parental ASFV CN/GS/2018 and ASFV-&#x00394;10L/&#x00394;7R at an MOI of 0.1 for 0, 24, and 48 h. After treatment, cells were washed with cold PBS and incubated on ice with NP-40 lysis buffer (Beyotime, Shanghai, China). Cell lysates were then clarified by centrifugation at 14,000 rpm for 20 min at 4 &#x000b0;C. Proteins were separated by SDS-PAGE and transferred onto polyvinylidene fluoride (PVDF) membranes (Cytiva, The Danaher Corporation, Washington, DC, USA). After treatment with the blocking buffer, the membrane was incubated with primary antibodies against targeted proteins overnight at 4 &#x000b0;C and then with the corresponding HRP-conjugated secondary antibodies at room temperature for 1 h. Protein expression was detected using a chemiluminescent HRP substrate (Merck-Millipore, Billerica, MA, USA). The blot images were obtained from an Amersham Imager 800 (GE Healthcare, Bangalore, India).</p></sec><sec id="sec2dot10-viruses-17-00283"><title>2.10. Transcriptome Sequencing (RNA-seq) and Analysis</title><p>BMDM cells were infected with ASFV CN/GS/2018 or ASFV-&#x00394;10L/&#x00394;7R at 0 h, 12 h, and 24 h and then collected for RNA extraction using TRIzol reagent (Vazyme, Nanjing, China). The RNA integrity and quality were assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) with a value of at least 7. Qualified total RNA was used as the starting sample, and the poly(A)-rich RNA in eukaryotic total RNA was enriched using the TIANSeq mRNA capture kit (TIANGEN Biotech, New York, NY, USA). The transcriptome sequencing library was constructed using the TIANSeq rapid RNA library construction kit (TIANGEN Biotech, Illumina platform). After library construction, the library was initially quantified using Qubit2.0, diluted to 1 ng/uL, and then the insert size was detected using an Agilent 2100 Bioanalyzer. After the insert size was confirmed, the effective concentration of the library was accurately quantified using Q-PCR (library effective concentration &#x0003e; 2 nM) to ensure library quality. The different libraries were pooled according to their effective concentrations and the target sequencing data volume requirements and then sequenced using the Illumina platform for PE150 sequencing to obtain 150 bp paired-end sequencing reads. Finally, the differentially expressed genes (DEGs) between ASFV CN/GS/2018- and ASFV-&#x00394;10L/&#x00394;7R-infected BMDM cells with a fold change of &#x02265;2 and a <italic toggle="yes">p</italic>-value &#x0003c; 0.05 were identified using DESeq2 (version 1.0.19) [<xref rid="B32-viruses-17-00283" ref-type="bibr">32</xref>]. Finally, the DEGs were enriched for KEGG and GO terms using the Biomart database.</p></sec><sec id="sec2dot11-viruses-17-00283"><title>2.11. Animal Experiments</title><p>The virulence and pathogenic mechanisms of ASFV-&#x00394;10L/&#x00394;7R compared to ASFV CN/GS/2018 were evaluated using mature commercial breeds of pigs. Different groups of pigs were inoculated with 10<sup>4</sup> HAD<sub>50</sub> of ASFV-CN/GS/2018 or ASFV-&#x00394;10L/&#x00394;7R. In the protection experiment, the experimental animal group (<italic toggle="yes">n</italic> = 3) was infected with 10<sup>2</sup> HAD<sub>50</sub> of the parental virus ASFV-CN/GS/2018 on day 20 to observe the immune protection provided by the deletion virus. In both experimental stages, the duration was 20 days, and clinical symptoms were monitored every day for both control and experimental groups, including body temperature and mortality rate. Meanwhile, blood was collected from the jugular vein, and serum was separated to detect the expression of viral DNA and anti-p30 antibodies. At the end of the experiment, the hearts, livers, spleens, lungs, kidneys, and lymph nodes of dead pigs or surviving pigs were collected. According to the requirements of the World Organisation for Animal Health (WOAH), surviving pigs were euthanized and their blood and tissues were safely disposed of to prevent the release of ASFV [<xref rid="B33-viruses-17-00283" ref-type="bibr">33</xref>].</p></sec><sec id="sec2dot12-viruses-17-00283"><title>2.12. Blocking ELISA</title><p>According to the instructions of the Block ELISA kit (Lanzhou Shouyan Biotechnology Co., Ltd.; Lanzhou, China), ASFV p30 specific antibody was detected in serum. When the colorimetric reaction was terminated, the results of the analysis of the optical density (OD<sub>450</sub>) value at 450 nm were read on an enzyme-labeled instrument, and the closure rate was calculated based on the standard curve independently established for each experimental datum. The cut-off value was 40.</p></sec><sec id="sec2dot13-viruses-17-00283"><title>2.13. Statistical Analysis</title><p>Statistical analysis was performed using GraphPad Prism 10, with data presented as mean values &#x000b1; standard errors of the mean (SEMs). A <italic toggle="yes">p</italic>-value &#x0003c; 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec3-viruses-17-00283"><title>3. Results</title><sec id="sec3dot1-viruses-17-00283"><title>3.1. ASFV-&#x00394;10L/&#x00394;7R Exhibited Lower Replication Capacity than ASFV CN/GS</title><p>Numerous studies have highlighted the critical role of the MGF360 and MGF505 gene families in ASFV pathogenicity. Deletions in MGF360 and/or MGF505, along with other genes, have been shown to reduce the virulence of parent strains and provide immune protection in recombinant viral vaccines [<xref rid="B26-viruses-17-00283" ref-type="bibr">26</xref>,<xref rid="B27-viruses-17-00283" ref-type="bibr">27</xref>,<xref rid="B28-viruses-17-00283" ref-type="bibr">28</xref>,<xref rid="B34-viruses-17-00283" ref-type="bibr">34</xref>]. To assess the effects of deleting <italic toggle="yes">MGF360-10L</italic> and <italic toggle="yes">MGF505-7R</italic> genes on ASFV CN/GS/2018, a genotype II strain endemic in China, we constructed ASFV-&#x00394;10L/&#x00394;7R using homologous recombination (<xref rid="viruses-17-00283-f001" ref-type="fig">Figure 1</xref>A). The <italic toggle="yes">MGF360-10L</italic> sequence was replaced with a p72eGFP reporter gene cassette and the virus was purified using porcine BMDM. The MGF505-7R sequence was then replaced with a p72mCherry reporter gene cassette, successfully generating the ASFV-&#x00394;10L/&#x00394;7R mutant, which was verified by fluorescence (<xref rid="viruses-17-00283-f001" ref-type="fig">Figure 1</xref>B). PCR analysis was performed using specific primers targeting the deletion sequence and B646L primers (internal control). No band was detected in the ASFV-&#x00394;10L/&#x00394;7R stock, confirming successful purification from the wild-type strain (<xref rid="viruses-17-00283-f001" ref-type="fig">Figure 1</xref>C). To evaluate potential off-target effects of the homologous recombination strategy used to generate the ASFV-GS-&#x00394;7R/&#x00394;I267L strain, the whole genomes of both the ASFV-GS-&#x00394;7R/&#x00394;I267L mutant and its parental strain were sequenced. Apart from the mutations at the targeted sites, the analysis revealed only four single nucleotide variations (SNVs) between the two genomes. These SNVs were located in the genes <italic toggle="yes">M1249L</italic>, <italic toggle="yes">D205R</italic>, and <italic toggle="yes">E199L</italic> (<xref rid="viruses-17-00283-t002" ref-type="table">Table 2</xref>). These variations appeared to result from viral replication and were unlikely to cause significant changes in viral virulence.</p><p>To assess the growth kinetics of ASFV-&#x00394;10L/&#x00394;7R in vitro, BMDM cells were infected with 0.01 MOI of ASFV CN/GS or ASFV-&#x00394;10L/&#x00394;7R. Viral genome copy numbers were measured at various time points post-infection. No significant differences were observed between ASFV and ASFV-&#x00394;10L/&#x00394;7R within the first 48 h of infection. However, after 48 h, the viral genome copy number of ASFV-&#x00394;10L/&#x00394;7R was significantly lower (<xref rid="viruses-17-00283-f001" ref-type="fig">Figure 1</xref>D) and its virus titer was also reduced compared to ASFV CN/GS (<xref rid="viruses-17-00283-f001" ref-type="fig">Figure 1</xref>E). Comparable results were obtained when measuring viral protein levels in infected cells (<xref rid="viruses-17-00283-f001" ref-type="fig">Figure 1</xref>F), further confirming that ASFV-&#x00394;10L/&#x00394;7R had a lower replication capacity than the parent strain.</p></sec><sec id="sec3dot2-viruses-17-00283"><title>3.2. ASFV-&#x00394;10L/&#x00394;7R Exhibited Significant Attenuation in Pigs</title><p>To evaluate the virulence of ASFV-&#x00394;10L/&#x00394;7R in vivo, two groups of pigs were inoculated with 10<sup>4</sup> HAD<sub>50</sub> of ASFV-&#x00394;10L/&#x00394;7R (<italic toggle="yes">n</italic> = 9) or ASFV CN/GS (<italic toggle="yes">n</italic> = 5), while a control group (<italic toggle="yes">n</italic> = 3) was housed with the ASFV-&#x00394;10L/&#x00394;7R-infected group. Clinical indicators, including temperature, were monitored and recorded for 20 days post-infection (dpi). As shown in <xref rid="viruses-17-00283-f002" ref-type="fig">Figure 2</xref>A, pigs in the ASFV CN/GS-infected group succumbed sequentially before 8 dpi, with body temperatures exceeding 40 &#x000b0;C by 3 dpi (<xref rid="viruses-17-00283-f002" ref-type="fig">Figure 2</xref>B). In contrast, no deaths or significant increases in body temperature were observed in the ASFV-&#x00394;10L/&#x00394;7R-infected group. Furthermore, the typical clinical signs of ASF were absent in the cohabitant pigs (<xref rid="viruses-17-00283-f002" ref-type="fig">Figure 2</xref>B). These results indicate that the deletion of the MGF360-10L and MGF505-7R genes completely attenuated the virulence of ASFV CN/GS. Viral load was assessed at different time points (<xref rid="viruses-17-00283-f002" ref-type="fig">Figure 2</xref>C), showing a high viral load in the blood of ASFV CN/GS-infected pigs, reaching approximately 10<sup>10</sup> HAD<sub>50</sub>/100 &#x003bc;L prior to death. In contrast, the viral load in ASFV-&#x00394;10L/&#x00394;7R-infected pigs was generally below 10<sup>3</sup> HAD<sub>50</sub>/100 &#x003bc;L, with even lower levels observed in the control group. While the immune mechanisms induced by ASFV CN/GS remain unclear, it is also uncertain whether infection with attenuated strains induces immune responses that confer protection against virulent strains. However, as is well established, humoral immunity plays a critical role in virus clearance [<xref rid="B35-viruses-17-00283" ref-type="bibr">35</xref>,<xref rid="B36-viruses-17-00283" ref-type="bibr">36</xref>,<xref rid="B37-viruses-17-00283" ref-type="bibr">37</xref>]. To assess the antibody response, we measured anti-p30 circulating antibody levels using a blocking ELISA. The results revealed a gradual increase in the p30 blocking rate following ASFV CN/GS infection, reaching a peak before death; however, the maximum value was far below the cut-off threshold. No significant difference in antibody levels was observed between ASFV-&#x00394;10L/&#x00394;7R-infected and control groups (<xref rid="viruses-17-00283-f002" ref-type="fig">Figure 2</xref>D), suggesting that ASFV-&#x00394;10L/&#x00394;7R did not induce a significant immune response in animals.</p></sec><sec id="sec3dot3-viruses-17-00283"><title>3.3. ASFV-&#x00394;10L/&#x00394;7R Did Not Induce Immune Protection Against Challenge with the Parental Strain</title><p>To evaluate the immune protection conferred by ASFV-&#x00394;10L/&#x00394;7R, we challenged animals with the parental virus after inoculation with the attenuated strain. As shown in <xref rid="viruses-17-00283-f003" ref-type="fig">Figure 3</xref>A, the experimental group (<italic toggle="yes">n</italic> = 9) was initially injected intramuscularly with 10<sup>4</sup> HAD<sub>50</sub> of ASFV-&#x00394;10L/&#x00394;7R, followed by a challenge with 10<sup>2</sup> HAD<sub>50</sub> of ASFV CN/GS at 20 dpi. Clinical symptoms and body temperature changes were monitored daily. In the ASFV-&#x00394;10L/&#x00394;7R group, deaths began at 6 days post-challenge (dpc) with ASFV CN/GS and were completed by 10 dpc, accompanied by an increase in body temperature, similar to the control group (<italic toggle="yes">n</italic> = 3), which was infected solely with ASFV (<xref rid="viruses-17-00283-f003" ref-type="fig">Figure 3</xref>B,C). All animals in the ASFV-&#x00394;10L/&#x00394;7R group were susceptible to challenge by the highly pathogenic parental strain. Viral gene copy numbers in various tissues, including the heart, liver, spleen, lungs, kidneys, submaxillary lymph nodes, hepato-gastric lymph nodes, and mesenteric lymph nodes, were not significantly different between ASFV-&#x00394;10L/&#x00394;7R-infected animals and those infected with the parental strain (<xref rid="viruses-17-00283-f003" ref-type="fig">Figure 3</xref>D). Similarly, anti-p30 circulating antibody levels did not show a significant increase (<xref rid="viruses-17-00283-f003" ref-type="fig">Figure 3</xref>E), indicating that ASFV-&#x00394;10L/&#x00394;7R failed to induce adequate immune protection in the host.</p><p>Histopathological examination (<xref rid="viruses-17-00283-f003" ref-type="fig">Figure 3</xref>F) revealed extensive pathological damage in the challenged group. Cardiac muscle fibers appeared deformed, liver cell arrangement was disrupted with loosely arranged cells and significant inflammatory cell infiltration, the red and white pulp of the spleen were disordered and loosely arranged, lung tissue exhibited edema and disorganized alveolar structures, renal tubules showed vacuole-like degeneration with increased interstitial space and loose arrangement, and submaxillary lymphoid tissue exhibited blurred gland boundaries, a marked reduction in blood vessels, and widespread red blood cell exudation across all tissues. These findings suggest that ASFV-&#x00394;10L/&#x00394;7R infection does not provide protection against a subsequent challenge by ASFV CN/GS, as evidenced by the lack of protective effects on tissue integrity.</p></sec><sec id="sec3dot4-viruses-17-00283"><title>3.4. Transcriptome Analysis of BMDM Cells Infected with ASFV CN/GS and ASFV-&#x00394;10L/&#x00394;7R</title><p>To further investigate the host cell response to ASFV CN/GS and ASFV-&#x00394;10L/&#x00394;7R infection, BMDM cell cultures were collected at various time points post-infection (<xref rid="viruses-17-00283-f004" ref-type="fig">Figure 4</xref>A), and RNA sequencing was performed as outlined in the workflow (<xref rid="viruses-17-00283-f004" ref-type="fig">Figure 4</xref>B). The sequencing data quality and base distributions for ASFV-&#x00394;10L/&#x00394;7R (left) and ASFV CN/GS (right) met experimental standards (<xref rid="viruses-17-00283-f004" ref-type="fig">Figure 4</xref>C,D). <xref rid="viruses-17-00283-f004" ref-type="fig">Figure 4</xref>E shows the number of differentially expressed genes (DEGs) for ASFV-&#x00394;10L/&#x00394;7R (2382 at 12 hpi and 2011 at 24 hpi) and ASFV CN/GS (2327 at 12 hpi and 2189 at 24 hpi) with statistical significance (<italic toggle="yes">p</italic> &#x0003c; 0.05, |log2FC| &#x0003e; 1). Notably, the expression of innate immune factors was higher in ASFV-&#x00394;10L/&#x00394;7R-infected cells than in those infected with the parental strain, suggesting that ASFV-&#x00394;10L/&#x00394;7R may induce a stronger host immune response. To investigate changes in biological signaling pathways, we performed KEGG pathway analysis of the DEGs from cells infected with ASFV-&#x00394;10L/&#x00394;7R and ASFV CN/GS at different time points. The analysis revealed that most DEGs were associated with immune-related pathways (<xref rid="viruses-17-00283-f005" ref-type="fig">Figure 5</xref>A,B), including NF-&#x003ba;B and JAK/STAT signaling. Scatter plot analysis further demonstrated that 138 and 67 DEGs were significantly downregulated at 12 and 24 hpi, respectively, while 9 and 40 DEGs were significantly upregulated (<xref rid="viruses-17-00283-f005" ref-type="fig">Figure 5</xref>C,D).</p></sec><sec id="sec3dot5-viruses-17-00283"><title>3.5. ASFV-&#x00394;10L/&#x00394;7R-Induced Upregulation of Immune Response-Related Factors Compared to ASFV CN/GS</title><p>To further analyze the function of DEGs in host responses, we conducted a Gene Ontology (GO) functional analysis and selected the top 10 most enriched terms. The results revealed that the immune response was the most significantly enriched biological process at 12 hpi (<xref rid="viruses-17-00283-f006" ref-type="fig">Figure 6</xref>A). Although the immune response decreased at 24 hpi (<xref rid="viruses-17-00283-f006" ref-type="fig">Figure 6</xref>B), it remained predominantly focused on the innate immune, the first line of defense. We selected thirty immune-related DEGs and visualized their expression profiles using a heatmap (<xref rid="viruses-17-00283-f006" ref-type="fig">Figure 6</xref>C,D). To verify these findings, qRT-PCR was performed to assess the expression of five key DEGs (<xref rid="viruses-17-00283-f007" ref-type="fig">Figure 7</xref>A,B). RNA sequencing analysis (<xref rid="viruses-17-00283-f007" ref-type="fig">Figure 7</xref>A) showed that the expression levels of <italic toggle="yes">CXCL10</italic>, <italic toggle="yes">ISG15</italic>, <italic toggle="yes">IFIT1</italic>, <italic toggle="yes">GBP1</italic>, and <italic toggle="yes">IFN-&#x003b2;</italic> were generally higher in ASFV-&#x00394;10L/&#x00394;7R-infected cells compared to ASFV CN/GS-infected cells (<xref rid="viruses-17-00283-f007" ref-type="fig">Figure 7</xref>B). As expected, mRNA levels of all five genes were upregulated in BMDM cells infected with ASFV-&#x00394;10L/&#x00394;7R, confirming the RNA sequencing results (<xref rid="viruses-17-00283-f007" ref-type="fig">Figure 7</xref>B).</p></sec></sec><sec sec-type="discussion" id="sec4-viruses-17-00283"><title>4. Discussion</title><p>Vaccine development based on viral genome modification is an active research field and plays a critical role in combating ASFV. In this study, we generated a novel mutant strain by deleting the <italic toggle="yes">MGF360-10L</italic> and <italic toggle="yes">MGF505-7R</italic> genes from the ASFV CN/GS/2018 genome. Our findings demonstrate that this mutant was completely attenuated in pigs but did not induce immune protection against a homologous challenge. Additionally, we observed differential cellular responses of BMDMs to ASFV-&#x00394;10L/&#x00394;7R and its parental strain.</p><p>Safety and efficacy are two critical factors in vaccine development, and both must be carefully balanced. Currently, the roles of ASFV virulence genes are not fully understood, and no single-gene deletion has been shown to meet both safety and efficacy requirements. A common approach involves targeting multiple genes. Previous studies have demonstrated that deleting the MGF360 and/or MGF505 family genes significantly attenuates ASFV strains and provides immune protection against the wild-type virus. These genes have been implicated in virulence attenuation and the suppression of IFN-I responses [<xref rid="B38-viruses-17-00283" ref-type="bibr">38</xref>,<xref rid="B39-viruses-17-00283" ref-type="bibr">39</xref>,<xref rid="B40-viruses-17-00283" ref-type="bibr">40</xref>,<xref rid="B41-viruses-17-00283" ref-type="bibr">41</xref>,<xref rid="B42-viruses-17-00283" ref-type="bibr">42</xref>,<xref rid="B43-viruses-17-00283" ref-type="bibr">43</xref>,<xref rid="B44-viruses-17-00283" ref-type="bibr">44</xref>]. However, their roles may vary between different ASFV isolates, and the impact of this variability on ASFV pathogenesis remains understudied. Deleting MGF505-7R in the ASFV HLJ/18 strain increases IL-1&#x003b2; and IFN-I production [<xref rid="B45-viruses-17-00283" ref-type="bibr">45</xref>], while the MGF505-7R gene from ASFV CN/GS inhibits IFN-II levels through the JAK-STAT signaling pathway [<xref rid="B46-viruses-17-00283" ref-type="bibr">46</xref>]. These findings suggest that MGF505-7R plays a key role in ASFV virulence. Although the mechanism of <italic toggle="yes">MGF360-10L</italic> remains unclear, deleting MGF360 family genes in the Benin 97/1 strain elevates IFN-&#x003b2; levels and confers protection against parental strain challenge [<xref rid="B26-viruses-17-00283" ref-type="bibr">26</xref>]. In this study, we constructed attenuated strains by deleting <italic toggle="yes">MGF360-10L</italic> and <italic toggle="yes">MGF505-7R</italic> from ASFV CN/GS/2018.</p><p>In vitro, ASFV-&#x00394;10L/&#x00394;7R showed significantly reduced replication capacity. The genome copy number decreased significantly at 72 hpi compared to the parental strain, with a notable decrease in viral titers at 48 hpi. This early decline may result from the deletion of these genes, which impairs both viral genome replication and gene translation. Western blot analysis confirmed the reduced expression of viral proteins p72, p54, and p30 at 48 hpi. These results suggest that MGF360-10L and MGF505-7R play key roles in viral genome replication and protein synthesis and potentially other stages of the ASFV life cycle, such as particle assembly or budding.</p><p>However, the virus challenge results indicate that ASFV-&#x00394;10L/&#x00394;7R is not a viable vaccine candidate as it failed to induce immune protection against the parental virus. The lack of significant p30-specific antibody production suggests that the mutant failed to elicit a protective ASFV-specific immune response. RNA-seq analysis showed that while innate immune factor expression was upregulated in ASFV-&#x00394;10L/&#x00394;7R-infected cells compared to the parental strain, this response was insufficient to prevent viral replication and protect against challenge. These results indicate that the deletion of <italic toggle="yes">MGF360-10L</italic> and <italic toggle="yes">MGF505-7R</italic> causes excessive attenuation, preventing the mutant from inducing an adequate immune response. An important observation from the inoculation experiment was the absence of significant temperature fluctuations, viremia, or p30-specific antibody responses in cohabiting animals. This suggests that ASFV-&#x00394;10L/&#x00394;7R does not transmit between animals after immunization, providing evidence that it could serve as a safe backbone for the development of more effective live attenuated vaccines (LAVs) against ASFV.</p><p>In conclusion, our results show that the ASFV-&#x00394;MGF360-10L/&#x00394;505-7R mutant derived from ASFV CN/GS/2018 is fully attenuated in pigs but fails to elicit a strong immune response, thus providing no protection against the parental strain. These findings provide valuable insights for the development of gene-deleted LAVs for ASFV.</p></sec></body><back><ack><title>Acknowledgments</title><p>We would like to express our heartfelt gratitude to our friends G.Q.-Z., C.C.-S, and Z.W.-S and the faculty members at the P3 facilities for their invaluable support and guidance. We are also deeply appreciative of Beijing Tangtang Tianxia Biotechnology Co., Ltd. for their assistance. Without the generous help of all these individuals and organizations, the completion of this thesis would not have been possible.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>H.Z., X.W. and T.F. conceived and designed the project. L.Z. and Z.Y. performed the experiments and conducted the data analysis. X.Q., Z.M., H.L., Z.Z. and J.R. helped with the experiments. D.L., J.P. and S.X. contributed analytic tools and provided valuable advice. L.Z., Z.Y. and T.F. wrote the manuscript with approval from all authors. H.Z. and T.F. supervised the project. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>All animals were handled in strict accordance with good animal practice according to the Animal Ethics Procedures and Guidelines of the People&#x02019;s Republic of China and this study was approved by the Animal Administration and Ethics Committee of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (permit no. LVRIAEC-2022-024).</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The raw data of RNA-seq generated during this study are available on the NCBI BioProject database (<uri xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/">https://www.ncbi.nlm.nih.gov/bioproject/</uri>) (accessed on 3 December 2024) under BioProject PRJNA1215345. Other data needed to evaluate the conclusions in this paper are present in the paper.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-viruses-17-00283"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alonso</surname><given-names>C.</given-names></name>
<name><surname>Borca</surname><given-names>M.</given-names></name>
<name><surname>Dixon</surname><given-names>L.</given-names></name>
<name><surname>Revilla</surname><given-names>Y.</given-names></name>
<name><surname>Rodriguez</surname><given-names>F.</given-names></name>
<name><surname>Escribano</surname><given-names>J.M.</given-names></name>
<collab>Ictv Report Consortium</collab>
</person-group><article-title>ICTV Virus Taxonomy Profile: Asfarviridae</article-title><source>J. Gen. Virol.</source><year>2018</year><volume>99</volume><fpage>613</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1099/jgv.0.001049</pub-id><pub-id pub-id-type="pmid">29565243</pub-id>
</element-citation></ref><ref id="B2-viruses-17-00283"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mighell</surname><given-names>E.</given-names></name>
<name><surname>Ward</surname><given-names>M.P.</given-names></name>
</person-group><article-title>African Swine Fever spread across Asia, 2018&#x02013;2019</article-title><source>Transbound. Emerg. Dis.</source><year>2021</year><volume>68</volume><fpage>2722</fpage><lpage>2732</lpage><pub-id pub-id-type="doi">10.1111/tbed.14039</pub-id><pub-id pub-id-type="pmid">33599077</pub-id>
</element-citation></ref><ref id="B3-viruses-17-00283"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zakaryan</surname><given-names>H.</given-names></name>
<name><surname>Cholakyans</surname><given-names>V.</given-names></name>
<name><surname>Simonyan</surname><given-names>L.</given-names></name>
<name><surname>Misakyan</surname><given-names>A.</given-names></name>
<name><surname>Karalova</surname><given-names>E.</given-names></name>
<name><surname>Chavushyan</surname><given-names>A.</given-names></name>
<name><surname>Karalyan</surname><given-names>Z.</given-names></name>
</person-group><article-title>A study of lymphoid organs and serum proinflammatory cytokines in pigs infected with African swine fever virus genotype II</article-title><source>Arch. Virol.</source><year>2015</year><volume>160</volume><fpage>1407</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.1007/s00705-015-2401-7</pub-id><pub-id pub-id-type="pmid">25797197</pub-id>
</element-citation></ref><ref id="B4-viruses-17-00283"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mulumba-Mfumu</surname><given-names>L.K.</given-names></name>
<name><surname>Saegerman</surname><given-names>C.</given-names></name>
<name><surname>Dixon</surname><given-names>L.K.</given-names></name>
<name><surname>Madimba</surname><given-names>K.C.</given-names></name>
<name><surname>Kazadi</surname><given-names>E.</given-names></name>
<name><surname>Mukalakata</surname><given-names>N.T.</given-names></name>
<name><surname>Oura</surname><given-names>C.A.L.</given-names></name>
<name><surname>Chenais</surname><given-names>E.</given-names></name>
<name><surname>Masembe</surname><given-names>C.</given-names></name>
<name><surname>St&#x000e5;hl</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>African swine fever: Update on Eastern, Central and Southern Africa</article-title><source>Transbound. Emerg. Dis.</source><year>2019</year><volume>66</volume><fpage>1462</fpage><lpage>1480</lpage><pub-id pub-id-type="doi">10.1111/tbed.13187</pub-id><pub-id pub-id-type="pmid">30920725</pub-id>
</element-citation></ref><ref id="B5-viruses-17-00283"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cwynar</surname><given-names>P.</given-names></name>
<name><surname>Stojkov</surname><given-names>J.</given-names></name>
<name><surname>Wlazlak</surname><given-names>K.</given-names></name>
</person-group><article-title>African Swine Fever Status in Europe</article-title><source>Viruses</source><year>2019</year><volume>11</volume><elocation-id>310</elocation-id><pub-id pub-id-type="doi">10.3390/v11040310</pub-id><pub-id pub-id-type="pmid">30935026</pub-id>
</element-citation></ref><ref id="B6-viruses-17-00283"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>N.</given-names></name>
<name><surname>Luo</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Miao</surname><given-names>F.</given-names></name>
<name><surname>Chen</surname><given-names>T.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
<name><surname>Cao</surname><given-names>P.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Tian</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Emergence of African Swine Fever in China, 2018</article-title><source>Transbound. Emerg. Dis.</source><year>2018</year><volume>65</volume><fpage>1482</fpage><lpage>1484</lpage><pub-id pub-id-type="doi">10.1111/tbed.12989</pub-id><pub-id pub-id-type="pmid">30102848</pub-id>
</element-citation></ref><ref id="B7-viruses-17-00283"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Costard</surname><given-names>S.</given-names></name>
<name><surname>Wieland</surname><given-names>B.</given-names></name>
<name><surname>de Glanville</surname><given-names>W.</given-names></name>
<name><surname>Jori</surname><given-names>F.</given-names></name>
<name><surname>Rowlands</surname><given-names>R.</given-names></name>
<name><surname>Vosloo</surname><given-names>W.</given-names></name>
<name><surname>Roger</surname><given-names>F.</given-names></name>
<name><surname>Pfeiffer</surname><given-names>D.U.</given-names></name>
<name><surname>Dixon</surname><given-names>L.K.</given-names></name>
</person-group><article-title>African swine fever: How can global spread be prevented?</article-title><source>Philos. Trans. R. Soc. Lond. B Biol. Sci.</source><year>2009</year><volume>364</volume><fpage>2683</fpage><lpage>2696</lpage><pub-id pub-id-type="doi">10.1098/rstb.2009.0098</pub-id><pub-id pub-id-type="pmid">19687038</pub-id>
</element-citation></ref><ref id="B8-viruses-17-00283"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Urbano</surname><given-names>A.C.</given-names></name>
<name><surname>Ferreira</surname><given-names>F.</given-names></name>
</person-group><article-title>African swine fever control and prevention: An update on vaccine development</article-title><source>Emerg. Microbes Infect.</source><year>2022</year><volume>11</volume><fpage>2021</fpage><lpage>2033</lpage><pub-id pub-id-type="doi">10.1080/22221751.2022.2108342</pub-id><pub-id pub-id-type="pmid">35912875</pub-id>
</element-citation></ref><ref id="B9-viruses-17-00283"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Y&#x000e1;&#x000f1;ez</surname><given-names>R.J.</given-names></name>
<name><surname>Rodr&#x000ed;guez</surname><given-names>J.M.</given-names></name>
<name><surname>Nogal</surname><given-names>M.L.</given-names></name>
<name><surname>Yuste</surname><given-names>L.</given-names></name>
<name><surname>Enr&#x000ed;quez</surname><given-names>C.</given-names></name>
<name><surname>Rodriguez</surname><given-names>J.F.</given-names></name>
<name><surname>Vi&#x000f1;uela</surname><given-names>E.</given-names></name>
</person-group><article-title>Analysis of the complete nucleotide sequence of African swine fever virus</article-title><source>Virology</source><year>1995</year><volume>208</volume><fpage>249</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1006/viro.1995.1149</pub-id><pub-id pub-id-type="pmid">11831707</pub-id>
</element-citation></ref><ref id="B10-viruses-17-00283"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chapman</surname><given-names>D.A.G.</given-names></name>
<name><surname>Tcherepanov</surname><given-names>V.</given-names></name>
<name><surname>Upton</surname><given-names>C.</given-names></name>
<name><surname>Dixon</surname><given-names>L.K.</given-names></name>
</person-group><article-title>Comparison of the genome sequences of non-pathogenic and pathogenic African swine fever virus isolates</article-title><source>J. Gen. Virol.</source><year>2008</year><volume>89</volume><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1099/vir.0.83343-0</pub-id><pub-id pub-id-type="pmid">18198370</pub-id>
</element-citation></ref><ref id="B11-viruses-17-00283"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>K.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Qu</surname><given-names>L.</given-names></name>
<name><surname>Gao</surname><given-names>G.F.</given-names></name>
<name><surname>Qiu</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Spatiotemporally Orchestrated Interactions between Viral and Cellular Proteins Involved in the Entry of African Swine Fever Virus</article-title><source>Viruses</source><year>2021</year><volume>13</volume><elocation-id>2495</elocation-id><pub-id pub-id-type="doi">10.3390/v13122495</pub-id><pub-id pub-id-type="pmid">34960765</pub-id>
</element-citation></ref><ref id="B12-viruses-17-00283"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dixon</surname><given-names>L.K.</given-names></name>
<name><surname>Chapman</surname><given-names>D.A.</given-names></name>
<name><surname>Netherton</surname><given-names>C.L.</given-names></name>
<name><surname>Upton</surname><given-names>C.</given-names></name>
</person-group><article-title>African swine fever virus replication and genomics</article-title><source>Virus Res.</source><year>2013</year><volume>173</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2012.10.020</pub-id><pub-id pub-id-type="pmid">23142553</pub-id>
</element-citation></ref><ref id="B13-viruses-17-00283"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Salas</surname><given-names>M.L.</given-names></name>
<name><surname>Andr&#x000e9;s</surname><given-names>G.</given-names></name>
</person-group><article-title>African swine fever virus morphogenesis</article-title><source>Virus Res.</source><year>2013</year><volume>173</volume><fpage>29</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2012.09.016</pub-id><pub-id pub-id-type="pmid">23059353</pub-id>
</element-citation></ref><ref id="B14-viruses-17-00283"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Luo</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Zhao</surname><given-names>Z.</given-names></name>
<name><surname>Bi</surname><given-names>Y.</given-names></name>
<name><surname>Sun</surname><given-names>J.</given-names></name>
<name><surname>Peng</surname><given-names>R.</given-names></name>
<name><surname>Song</surname><given-names>H.</given-names></name>
<name><surname>Zhu</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Cryo-EM Structure of the African Swine Fever Virus</article-title><source>Cell Host Microbe</source><year>2019</year><volume>26</volume><fpage>836</fpage><lpage>843.e3</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2019.11.004</pub-id><pub-id pub-id-type="pmid">31787524</pub-id>
</element-citation></ref><ref id="B15-viruses-17-00283"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>N.</given-names></name>
<name><surname>Zhao</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>M.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>F.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Bu</surname><given-names>Z.</given-names></name>
<name><surname>Rao</surname><given-names>Z.</given-names></name>
<etal/>
</person-group><article-title>Architecture of African swine fever virus and implications for viral assembly</article-title><source>Science</source><year>2019</year><volume>366</volume><fpage>640</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1126/science.aaz1439</pub-id><pub-id pub-id-type="pmid">31624094</pub-id>
</element-citation></ref><ref id="B16-viruses-17-00283"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andr&#x000e9;s</surname><given-names>G.</given-names></name>
<name><surname>Charro</surname><given-names>D.</given-names></name>
<name><surname>Matamoros</surname><given-names>T.</given-names></name>
<name><surname>Dillard</surname><given-names>R.S.</given-names></name>
<name><surname>Abrescia</surname><given-names>N.G.A.</given-names></name>
</person-group><article-title>The cryo-EM structure of African swine fever virus unravels a unique architecture comprising two icosahedral protein capsids and two lipoprotein membranes</article-title><source>J. Biol. Chem.</source><year>2020</year><volume>295</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1074/jbc.AC119.011196</pub-id><pub-id pub-id-type="pmid">31649031</pub-id>
</element-citation></ref><ref id="B17-viruses-17-00283"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blome</surname><given-names>S.</given-names></name>
<name><surname>Gabriel</surname><given-names>C.</given-names></name>
<name><surname>Beer</surname><given-names>M.</given-names></name>
</person-group><article-title>Modern adjuvants do not enhance the efficacy of an inactivated African swine fever virus vaccine preparation</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><fpage>3879</fpage><lpage>3882</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2014.05.051</pub-id><pub-id pub-id-type="pmid">24877766</pub-id>
</element-citation></ref><ref id="B18-viruses-17-00283"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rock</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Challenges for African swine fever vaccine development&#x02014;&#x0201c;&#x02026; perhaps the end of the beginning.&#x0201d;</article-title><source>Vet. Microbiol.</source><year>2017</year><volume>206</volume><fpage>52</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2016.10.003</pub-id><pub-id pub-id-type="pmid">27756505</pub-id>
</element-citation></ref><ref id="B19-viruses-17-00283"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Argilaguet</surname><given-names>J.M.</given-names></name>
<name><surname>P&#x000e9;rez-Mart&#x000ed;n</surname><given-names>E.</given-names></name>
<name><surname>Gallardo</surname><given-names>C.</given-names></name>
<name><surname>Salguero</surname><given-names>F.J.</given-names></name>
<name><surname>Borrego</surname><given-names>B.</given-names></name>
<name><surname>Lacasta</surname><given-names>A.</given-names></name>
<name><surname>Accensi</surname><given-names>F.</given-names></name>
<name><surname>D&#x000ed;az</surname><given-names>I.</given-names></name>
<name><surname>Nofrar&#x000ed;as</surname><given-names>M.</given-names></name>
<name><surname>Pujols</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells</article-title><source>Vaccine</source><year>2011</year><volume>29</volume><fpage>5379</fpage><lpage>5385</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2011.05.084</pub-id><pub-id pub-id-type="pmid">21679736</pub-id>
</element-citation></ref><ref id="B20-viruses-17-00283"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Argilaguet</surname><given-names>J.M.</given-names></name>
<name><surname>P&#x000e9;rez-Mart&#x000ed;n</surname><given-names>E.</given-names></name>
<name><surname>Nofrar&#x000ed;as</surname><given-names>M.</given-names></name>
<name><surname>Gallardo</surname><given-names>C.</given-names></name>
<name><surname>Accensi</surname><given-names>F.</given-names></name>
<name><surname>Lacasta</surname><given-names>A.</given-names></name>
<name><surname>Mora</surname><given-names>M.</given-names></name>
<name><surname>Ballester</surname><given-names>M.</given-names></name>
<name><surname>Galindo-Cardiel</surname><given-names>I.</given-names></name>
<name><surname>L&#x000f3;pez-Soria</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e40942</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0040942</pub-id><pub-id pub-id-type="pmid">23049728</pub-id>
</element-citation></ref><ref id="B21-viruses-17-00283"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lacasta</surname><given-names>A.</given-names></name>
<name><surname>Ballester</surname><given-names>M.</given-names></name>
<name><surname>Monteagudo</surname><given-names>P.L.</given-names></name>
<name><surname>Rodr&#x000ed;guez</surname><given-names>J.M.</given-names></name>
<name><surname>Salas</surname><given-names>M.L.</given-names></name>
<name><surname>Accensi</surname><given-names>F.</given-names></name>
<name><surname>Pina-Pedrero</surname><given-names>S.</given-names></name>
<name><surname>Bensaid</surname><given-names>A.</given-names></name>
<name><surname>Argilaguet</surname><given-names>J.</given-names></name>
<name><surname>L&#x000f3;pez-Soria</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Expression library immunization can confer protection against lethal challenge with African swine fever virus</article-title><source>J. Virol.</source><year>2014</year><volume>88</volume><fpage>13322</fpage><lpage>13332</lpage><pub-id pub-id-type="doi">10.1128/JVI.01893-14</pub-id><pub-id pub-id-type="pmid">25210179</pub-id>
</element-citation></ref><ref id="B22-viruses-17-00283"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cadenas-Fern&#x000e1;ndez</surname><given-names>E.</given-names></name>
<name><surname>S&#x000e1;nchez-Vizca&#x000ed;no</surname><given-names>J.M.</given-names></name>
<name><surname>Kosowska</surname><given-names>A.</given-names></name>
<name><surname>Rivera</surname><given-names>B.</given-names></name>
<name><surname>Mayoral-Alegre</surname><given-names>F.</given-names></name>
<name><surname>Rodr&#x000ed;guez-Bertos</surname><given-names>A.</given-names></name>
<name><surname>Yao</surname><given-names>J.</given-names></name>
<name><surname>Bray</surname><given-names>J.</given-names></name>
<name><surname>Lokhandwala</surname><given-names>S.</given-names></name>
<name><surname>Mwangi</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>Adenovirus-vectored African Swine Fever Virus Antigens Cocktail Is Not Protective against Virulent Arm07 Isolate in Eurasian Wild Boar</article-title><source>Pathogens</source><year>2020</year><volume>9</volume><elocation-id>171</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens9030171</pub-id><pub-id pub-id-type="pmid">32121082</pub-id>
</element-citation></ref><ref id="B23-viruses-17-00283"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lokhandwala</surname><given-names>S.</given-names></name>
<name><surname>Waghela</surname><given-names>S.D.</given-names></name>
<name><surname>Bray</surname><given-names>J.</given-names></name>
<name><surname>Martin</surname><given-names>C.L.</given-names></name>
<name><surname>Sangewar</surname><given-names>N.</given-names></name>
<name><surname>Charendoff</surname><given-names>C.</given-names></name>
<name><surname>Shetti</surname><given-names>R.</given-names></name>
<name><surname>Ashley</surname><given-names>C.</given-names></name>
<name><surname>Chen</surname><given-names>C.H.</given-names></name>
<name><surname>Berghman</surname><given-names>L.R.</given-names></name>
<etal/>
</person-group><article-title>Induction of Robust Immune Responses in Swine by Using a Cocktail of Adenovirus-Vectored African Swine Fever Virus Antigens</article-title><source>Clin. Vaccine Immunol.</source><year>2016</year><volume>23</volume><fpage>888</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1128/CVI.00395-16</pub-id><pub-id pub-id-type="pmid">27628166</pub-id>
</element-citation></ref><ref id="B24-viruses-17-00283"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lokhandwala</surname><given-names>S.</given-names></name>
<name><surname>Waghela</surname><given-names>S.D.</given-names></name>
<name><surname>Bray</surname><given-names>J.</given-names></name>
<name><surname>Sangewar</surname><given-names>N.</given-names></name>
<name><surname>Charendoff</surname><given-names>C.</given-names></name>
<name><surname>Martin</surname><given-names>C.L.</given-names></name>
<name><surname>Hassan</surname><given-names>W.S.</given-names></name>
<name><surname>Koynarski</surname><given-names>T.</given-names></name>
<name><surname>Gabbert</surname><given-names>L.</given-names></name>
<name><surname>Burrage</surname><given-names>T.G.</given-names></name>
<etal/>
</person-group><article-title>Adenovirus-vectored novel African Swine Fever Virus antigens elicit robust immune responses in swine</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0177007</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0177007</pub-id><pub-id pub-id-type="pmid">28481911</pub-id>
</element-citation></ref><ref id="B25-viruses-17-00283"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Imbery</surname><given-names>J.</given-names></name>
<name><surname>Upton</surname><given-names>C.</given-names></name>
</person-group><article-title>Organization of the multigene families of African Swine Fever Virus</article-title><source>Fine Focus</source><year>2017</year><volume>3</volume><fpage>155</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.33043/FF.3.2.155-170</pub-id></element-citation></ref><ref id="B26-viruses-17-00283"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reis</surname><given-names>A.L.</given-names></name>
<name><surname>Abrams</surname><given-names>C.C.</given-names></name>
<name><surname>Goatley</surname><given-names>L.C.</given-names></name>
<name><surname>Netherton</surname><given-names>C.</given-names></name>
<name><surname>Chapman</surname><given-names>D.G.</given-names></name>
<name><surname>Sanchez-Cordon</surname><given-names>P.</given-names></name>
<name><surname>Dixon</surname><given-names>L.K.</given-names></name>
</person-group><article-title>Deletion of African swine fever virus interferon inhibitors from the genome of a virulent isolate reduces virulence in domestic pigs and induces a protective response</article-title><source>Vaccine</source><year>2016</year><volume>34</volume><fpage>4698</fpage><lpage>4705</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2016.08.011</pub-id><pub-id pub-id-type="pmid">27521231</pub-id>
</element-citation></ref><ref id="B27-viruses-17-00283"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gao</surname><given-names>Q.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Quan</surname><given-names>W.</given-names></name>
<name><surname>Zheng</surname><given-names>J.</given-names></name>
<name><surname>Luo</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Huang</surname><given-names>Z.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Xu</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>The African Swine Fever Virus with MGF360 and MGF505 Deleted Reduces the Apoptosis of Porcine Alveolar Macrophages by Inhibiting the NF-&#x003ba;B Signaling Pathway and Interleukin-1&#x003b2;</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><elocation-id>1371</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9111371</pub-id><pub-id pub-id-type="pmid">34835302</pub-id>
</element-citation></ref><ref id="B28-viruses-17-00283"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rathakrishnan</surname><given-names>A.</given-names></name>
<name><surname>Connell</surname><given-names>S.</given-names></name>
<name><surname>Petrovan</surname><given-names>V.</given-names></name>
<name><surname>Moffat</surname><given-names>K.</given-names></name>
<name><surname>Goatley</surname><given-names>L.C.</given-names></name>
<name><surname>Jabbar</surname><given-names>T.</given-names></name>
<name><surname>S&#x000e1;nchez-Cord&#x000f3;n</surname><given-names>P.J.</given-names></name>
<name><surname>Reis</surname><given-names>A.L.</given-names></name>
<name><surname>Dixon</surname><given-names>L.K.</given-names></name>
</person-group><article-title>Differential Effect of Deleting Members of African Swine Fever Virus Multigene Families 360 and 505 from the Genotype II Georgia 2007/1 Isolate on Virus Replication, Virulence, and Induction of Protection</article-title><source>J. Virol.</source><year>2022</year><volume>96</volume><fpage>e0189921</fpage><pub-id pub-id-type="doi">10.1128/jvi.01899-21</pub-id><pub-id pub-id-type="pmid">35044212</pub-id>
</element-citation></ref><ref id="B29-viruses-17-00283"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gao</surname><given-names>J.</given-names></name>
<name><surname>Scheenstra</surname><given-names>M.R.</given-names></name>
<name><surname>van Dijk</surname><given-names>A.</given-names></name>
<name><surname>Veldhuizen</surname><given-names>E.J.A.</given-names></name>
<name><surname>Haagsman</surname><given-names>H.P.</given-names></name>
</person-group><article-title>A new and efficient culture method for porcine bone marrow-derived M1- and M2-polarized macrophages</article-title><source>Vet. Immunol. Immunopathol.</source><year>2018</year><volume>200</volume><fpage>7</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2018.04.002</pub-id><pub-id pub-id-type="pmid">29776615</pub-id>
</element-citation></ref><ref id="B30-viruses-17-00283"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malmquist</surname><given-names>W.A.</given-names></name>
<name><surname>Hay</surname><given-names>D.</given-names></name>
</person-group><article-title>Hemadsorption and cytopathic effect produced by African Swine Fever virus in swine bone marrow and buffy coat cultures</article-title><source>Am. J. Vet. Res.</source><year>1960</year><volume>21</volume><fpage>104</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">14420403</pub-id>
</element-citation></ref><ref id="B31-viruses-17-00283"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reed</surname><given-names>L.J.</given-names></name>
<name><surname>Muench</surname><given-names>H.</given-names></name>
</person-group><article-title>A simple method of estimating fifty percent endpoints</article-title><source>Am. J. Hyg.</source><year>1938</year><volume>27</volume><fpage>493</fpage><lpage>497</lpage></element-citation></ref><ref id="B32-viruses-17-00283"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Love</surname><given-names>M.I.</given-names></name>
<name><surname>Huber</surname><given-names>W.</given-names></name>
<name><surname>Anders</surname><given-names>S.</given-names></name>
</person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biol.</source><year>2014</year><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id>
</element-citation></ref><ref id="B33-viruses-17-00283"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>King</surname><given-names>D.P.</given-names></name>
<name><surname>Reid</surname><given-names>S.M.</given-names></name>
<name><surname>Hutchings</surname><given-names>G.H.</given-names></name>
<name><surname>Grierson</surname><given-names>S.S.</given-names></name>
<name><surname>Wilkinson</surname><given-names>P.J.</given-names></name>
<name><surname>Dixon</surname><given-names>L.K.</given-names></name>
<name><surname>Bastos</surname><given-names>A.D.</given-names></name>
<name><surname>Drew</surname><given-names>T.W.</given-names></name>
</person-group><article-title>Development of a TaqMan PCR assay with internal amplification control for the detection of African swine fever virus</article-title><source>J. Virol. Methods</source><year>2003</year><volume>107</volume><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/S0166-0934(02)00189-1</pub-id><pub-id pub-id-type="pmid">12445938</pub-id>
</element-citation></ref><ref id="B34-viruses-17-00283"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koltsov</surname><given-names>A.</given-names></name>
<name><surname>Sukher</surname><given-names>M.</given-names></name>
<name><surname>Krutko</surname><given-names>S.</given-names></name>
<name><surname>Belov</surname><given-names>S.</given-names></name>
<name><surname>Korotin</surname><given-names>A.</given-names></name>
<name><surname>Rudakova</surname><given-names>S.</given-names></name>
<name><surname>Morgunov</surname><given-names>S.</given-names></name>
<name><surname>Koltsova</surname><given-names>G.</given-names></name>
</person-group><article-title>Construction of the First Russian Recombinant Live Attenuated Vaccine Strain and Evaluation of Its Protection Efficacy Against Two African Swine Fever Virus Heterologous Strains of Serotype 8</article-title><source>Vaccines</source><year>2024</year><volume>12</volume><elocation-id>1443</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines12121443</pub-id><pub-id pub-id-type="pmid">39772103</pub-id>
</element-citation></ref><ref id="B35-viruses-17-00283"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schlafer</surname><given-names>D.H.</given-names></name>
<name><surname>McVicar</surname><given-names>J.W.</given-names></name>
<name><surname>Mebus</surname><given-names>C.A.</given-names></name>
</person-group><article-title>African swine fever convalescent sows: Subsequent pregnancy and the effect of colostral antibody on challenge inoculation of their pigs</article-title><source>Am. J. Vet. Res.</source><year>1984</year><volume>45</volume><fpage>1361</fpage><lpage>1366</lpage><pub-id pub-id-type="doi">10.2460/ajvr.1984.45.07.1361</pub-id><pub-id pub-id-type="pmid">24049898</pub-id>
</element-citation></ref><ref id="B36-viruses-17-00283"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schlafer</surname><given-names>D.H.</given-names></name>
<name><surname>Mebus</surname><given-names>C.A.</given-names></name>
<name><surname>McVicar</surname><given-names>J.W.</given-names></name>
</person-group><article-title>African swine fever in neonatal pigs: Passively acquired protection from colostrum or serum of recovered pigs</article-title><source>Am. J. Vet. Res.</source><year>1984</year><volume>45</volume><fpage>1367</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.2460/ajvr.1984.45.07.1367</pub-id><pub-id pub-id-type="pmid">24049899</pub-id>
</element-citation></ref><ref id="B37-viruses-17-00283"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Onisk</surname><given-names>D.V.</given-names></name>
<name><surname>Borca</surname><given-names>M.V.</given-names></name>
<name><surname>Kutish</surname><given-names>G.</given-names></name>
<name><surname>Kramer</surname><given-names>E.</given-names></name>
<name><surname>Irusta</surname><given-names>P.</given-names></name>
<name><surname>Rock</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Passively transferred African swine fever virus antibodies protect swine against lethal infection</article-title><source>Virology</source><year>1994</year><volume>198</volume><fpage>350</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1006/viro.1994.1040</pub-id><pub-id pub-id-type="pmid">8259670</pub-id>
</element-citation></ref><ref id="B38-viruses-17-00283"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>K.</given-names></name>
<name><surname>Huang</surname><given-names>Q.</given-names></name>
<name><surname>Wang</surname><given-names>R.</given-names></name>
<name><surname>Zeng</surname><given-names>Y.</given-names></name>
<name><surname>Cheng</surname><given-names>M.</given-names></name>
<name><surname>Xue</surname><given-names>Y.</given-names></name>
<name><surname>Shi</surname><given-names>C.</given-names></name>
<name><surname>Ye</surname><given-names>L.</given-names></name>
<name><surname>Yang</surname><given-names>W.</given-names></name>
<name><surname>Jiang</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>African swine fever virus MGF505-11R inhibits type I interferon production by negatively regulating the cGAS-STING-mediated signaling pathway</article-title><source>Vet. Microbiol.</source><year>2021</year><volume>263</volume><elocation-id>109265</elocation-id><pub-id pub-id-type="doi">10.1016/j.vetmic.2021.109265</pub-id><pub-id pub-id-type="pmid">34710767</pub-id>
</element-citation></ref><ref id="B39-viruses-17-00283"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yao</surname><given-names>M.</given-names></name>
<name><surname>Cao</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Hu</surname><given-names>Z.</given-names></name>
<name><surname>Rong</surname><given-names>Z.</given-names></name>
<name><surname>Yin</surname><given-names>M.</given-names></name>
<name><surname>Tian</surname><given-names>L.</given-names></name>
<name><surname>Hu</surname><given-names>D.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Qian</surname><given-names>P.</given-names></name>
</person-group><article-title>African swine fever virus MGF505-6R attenuates type I interferon production by targeting STING for degradation</article-title><source>Front. Immunol.</source><year>2024</year><volume>15</volume><elocation-id>1380220</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2024.1380220</pub-id><pub-id pub-id-type="pmid">38799458</pub-id>
</element-citation></ref><ref id="B40-viruses-17-00283"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dupr&#x000e9;</surname><given-names>J.</given-names></name>
<name><surname>Le Dimna</surname><given-names>M.</given-names></name>
<name><surname>Hutet</surname><given-names>E.</given-names></name>
<name><surname>Dujardin</surname><given-names>P.</given-names></name>
<name><surname>Fablet</surname><given-names>A.</given-names></name>
<name><surname>Leroy</surname><given-names>A.</given-names></name>
<name><surname>Fleurot</surname><given-names>I.</given-names></name>
<name><surname>Karadjian</surname><given-names>G.</given-names></name>
<name><surname>Roesch</surname><given-names>F.</given-names></name>
<name><surname>Caballero</surname><given-names>I.</given-names></name>
<etal/>
</person-group><article-title>Exploring type I interferon pathway: Virulent vs. attenuated strain of African swine fever virus revealing a novel function carried by MGF505-4R</article-title><source>Front. Immunol.</source><year>2024</year><volume>15</volume><elocation-id>1358219</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2024.1358219</pub-id><pub-id pub-id-type="pmid">38529285</pub-id>
</element-citation></ref><ref id="B41-viruses-17-00283"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Q.</given-names></name>
<name><surname>Wang</surname><given-names>X.X.</given-names></name>
<name><surname>Jiang</surname><given-names>S.W.</given-names></name>
<name><surname>Gao</surname><given-names>X.T.</given-names></name>
<name><surname>Huang</surname><given-names>S.Y.</given-names></name>
<name><surname>Liang</surname><given-names>Y.</given-names></name>
<name><surname>Jia</surname><given-names>H.</given-names></name>
<name><surname>Zhu</surname><given-names>H.F.</given-names></name>
</person-group><article-title>MGF360-12L of ASFV-SY18 is an immune-evasion protein that inhibits host type I IFN, NF-&#x003ba;B, and JAK/STAT pathways</article-title><source>Pol. J. Vet. Sci.</source><year>2023</year><volume>26</volume><fpage>119</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.24425/pjvs.2023.145013</pub-id><pub-id pub-id-type="pmid">36961276</pub-id>
</element-citation></ref><ref id="B42-viruses-17-00283"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>K.</given-names></name>
<name><surname>Yang</surname><given-names>B.</given-names></name>
<name><surname>Shen</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>T.</given-names></name>
<name><surname>Hao</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>D.</given-names></name>
<name><surname>Liu</surname><given-names>H.</given-names></name>
<name><surname>Shi</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>G.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>MGF360-9L Is a Major Virulence Factor Associated with the African Swine Fever Virus by Antagonizing the JAK/STAT Signaling Pathway</article-title><source>mBio</source><year>2022</year><volume>13</volume><elocation-id>e0233021</elocation-id><pub-id pub-id-type="doi">10.1128/mbio.02330-21</pub-id><pub-id pub-id-type="pmid">35076286</pub-id>
</element-citation></ref><ref id="B43-viruses-17-00283"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ding</surname><given-names>M.</given-names></name>
<name><surname>Dang</surname><given-names>W.</given-names></name>
<name><surname>Liu</surname><given-names>H.</given-names></name>
<name><surname>Xu</surname><given-names>F.</given-names></name>
<name><surname>Huang</surname><given-names>H.</given-names></name>
<name><surname>Sunkang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>T.</given-names></name>
<name><surname>Pei</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Combinational Deletions of MGF360-9L and MGF505-7R Attenuated Highly Virulent African Swine Fever Virus and Conferred Protection against Homologous Challenge</article-title><source>J. Virol.</source><year>2022</year><volume>96</volume><fpage>e0032922</fpage><pub-id pub-id-type="doi">10.1128/jvi.00329-22</pub-id><pub-id pub-id-type="pmid">35867564</pub-id>
</element-citation></ref><ref id="B44-viruses-17-00283"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Golding</surname><given-names>J.P.</given-names></name>
<name><surname>Goatley</surname><given-names>L.</given-names></name>
<name><surname>Goodbourn</surname><given-names>S.</given-names></name>
<name><surname>Dixon</surname><given-names>L.K.</given-names></name>
<name><surname>Taylor</surname><given-names>G.</given-names></name>
<name><surname>Netherton</surname><given-names>C.L.</given-names></name>
</person-group><article-title>Sensitivity of African swine fever virus to type I interferon is linked to genes within multigene families 360 and 505</article-title><source>Virology</source><year>2016</year><volume>493</volume><fpage>154</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2016.03.019</pub-id><pub-id pub-id-type="pmid">27043071</pub-id>
</element-citation></ref><ref id="B45-viruses-17-00283"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Song</surname><given-names>J.</given-names></name>
<name><surname>Kang</surname><given-names>L.</given-names></name>
<name><surname>Huang</surname><given-names>L.</given-names></name>
<name><surname>Zhou</surname><given-names>S.</given-names></name>
<name><surname>Hu</surname><given-names>L.</given-names></name>
<name><surname>Zheng</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>He</surname><given-names>X.</given-names></name>
<etal/>
</person-group><article-title>pMGF505-7R determines pathogenicity of African swine fever virus infection by inhibiting IL-1&#x003b2; and type I IFN production</article-title><source>PLoS Pathog.</source><year>2021</year><volume>17</volume><elocation-id>e1009733</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009733</pub-id><pub-id pub-id-type="pmid">34310655</pub-id>
</element-citation></ref><ref id="B46-viruses-17-00283"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>W.</given-names></name>
<name><surname>Li</surname><given-names>P.</given-names></name>
<name><surname>Ru</surname><given-names>Y.</given-names></name>
<name><surname>Kang</surname><given-names>W.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Ran</surname><given-names>Y.</given-names></name>
<name><surname>Zheng</surname><given-names>H.</given-names></name>
</person-group><article-title>African swine fever virus protein MGF-505-7R promotes virulence and pathogenesis by inhibiting JAK1- and JAK2-mediated signaling</article-title><source>J. Biol. Chem.</source><year>2021</year><volume>297</volume><elocation-id>101190</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2021.101190</pub-id><pub-id pub-id-type="pmid">34517008</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="viruses-17-00283-f001"><label>Figure 1</label><caption><p>Construction and growth dynamics of the ASFV-&#x00394;10L/&#x00394;7R mutant. (<bold>A</bold>) Schematic diagram of the deletion of the <italic toggle="yes">MGF360-10L</italic> and <italic toggle="yes">MGF505-7R</italic> gene regions in ASFV CN/GS/2018. The <italic toggle="yes">MGF360-10L</italic> sequence was replaced with a p72-eGFP reporter gene cassette. The <italic toggle="yes">MGF505-7R</italic> sequence was replaced with a p72-mCherry reporter gene cassette in the ASFV-&#x00394;MGF360-10L deletion strain. (<bold>B</bold>) Fluorescent expression in ASFV-&#x00394;10L/&#x00394;7R-infected BMDMs. Scale bar: 300 &#x003bc;m. (<bold>C</bold>) PCR verification of the deletion virus genome using specific primers for <italic toggle="yes">MGF505-7R</italic>, <italic toggle="yes">MGF360-10L</italic>, and the positive control <italic toggle="yes">B646L</italic> (p72). &#x02217;, nonspecific bands. (<bold>D</bold>) Viral DNA replication of ASFV CN/GS and ASFV-&#x00394;10L/&#x00394;7R. BMDMs were infected with ASFV CN/GS or ASFV-&#x00394;10L/&#x00394;7R (0.01 MOI) and viral genome copies were quantified at different time points. (<bold>E</bold>) Growth curves of ASFV CN/GS/2018 and ASFV-&#x00394;10L/&#x00394;7R. BMDMs were infected with ASFV CN/GS or ASFV-&#x00394;10L/&#x00394;7R (0.01 MOI) and viral titers were determined by red blood cell hemagglutination assays at various time points. (<bold>F</bold>) Expression of p72, p54, and p30 in ASFV CN/GS or ASFV-&#x00394;10L/&#x00394;7R at different time points. BMDMs were infected with ASFV CN/GS or ASFV-&#x00394;10L/&#x00394;7R (0.1 MOI), respectively. Samples were collected at 2, 24, and 48 h post-infection and Western blotting was performed. Data represent at least three independent experiments (<bold>D</bold>&#x02013;<bold>F</bold>). [(<bold>D</bold>,<bold>E</bold>)] are presented as mean &#x000b1; SEM of three biological replicates and were analyzed by one-way ANOVA. (<bold>F</bold>) Data are representative of three independent experiments. ns for <italic toggle="yes">p</italic> &#x0003e; 0.05, *** <italic toggle="yes">p</italic> &#x0003c; 0.001, **** <italic toggle="yes">p</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="viruses-17-00283-g001" position="float"/></fig><fig position="float" id="viruses-17-00283-f002"><label>Figure 2</label><caption><p>Evaluation of the virulence of ASFV-&#x00394;10L/&#x00394;7R at the animal level. (<bold>A</bold>) Pigs were injected intramuscularly with ASFV CN/GS or ASFV-&#x00394;10L/&#x00394;7R (10&#x02074; HAD<sub>50</sub>), followed by analyses of survival rates (<bold>A</bold>), thermodynamics (<bold>B</bold>), viral load in the blood (<bold>C</bold>), and p30-specific antibody levels (<bold>D</bold>). [(<bold>C</bold>,<bold>D</bold>)] Data are presented as mean &#x000b1; SEM of three biological replicates.</p></caption><graphic xlink:href="viruses-17-00283-g002" position="float"/></fig><fig position="float" id="viruses-17-00283-f003"><label>Figure 3</label><caption><p>The immune protection response of pigs induced by ASFV CN/GS challenge. (<bold>A</bold>) Immunization and challenge model: 10&#x02074; HAD<sub>50</sub> of ASFV-&#x00394;10L/&#x00394;7R was injected intramuscularly into pigs, followed by a challenge with 10<sup>2</sup> HAD<sub>50</sub> of ASFV CN/GS 20 days later. Animal parameters were evaluated at different time points after challenge, including survival rate (<bold>B</bold>), thermodynamics (<bold>C</bold>), viral load in various tissues (<bold>D</bold>), and p30-specific antibody levels (<bold>E</bold>). (<bold>F</bold>) Comparison of characteristic histopathological changes between the healthy group and ASFV-&#x00394;10L/&#x00394;7R-infected animals after challenge with ASFV CN/GS. [(<bold>D</bold>,<bold>E</bold>)] Data are presented as mean &#x000b1; SEM of three biological replicates and (<bold>D</bold>) was analyzed by two-way ANOVA. ns for <italic toggle="yes">p</italic> &#x0003e; 0.05.</p></caption><graphic xlink:href="viruses-17-00283-g003" position="float"/></fig><fig position="float" id="viruses-17-00283-f004"><label>Figure 4</label><caption><p>Experimental design and quality assessment of RNA-seq for ASFV-&#x00394;10L/&#x00394;7R. [(<bold>A</bold>,<bold>B</bold>)] Experimental design and RNA-seq sequencing process. (<bold>A</bold>) BMDM cells were infected with 0.1 MOI of ASFV CN/GS or ASFV-&#x00394;10L/&#x00394;7R, and samples were collected at 12 h and 24 h for analysis. (<bold>B</bold>) Samples from (<bold>A</bold>) were prepared and processed for bioinformatics sequencing. [(<bold>C</bold>,<bold>D</bold>)] Quality distribution (<bold>C</bold>) and base composition (<bold>D</bold>) of the original sequencing data for ASFV CN/GS and ASFV-&#x00394;10L/&#x00394;7R. (<bold>E</bold>) Venn diagram showing differentially expressed genes (DEGs) in ASFV CN/GS and ASFV-&#x00394;10L/&#x00394;7R at different infection times.</p></caption><graphic xlink:href="viruses-17-00283-g004" position="float"/></fig><fig position="float" id="viruses-17-00283-f005"><label>Figure 5</label><caption><p>Analysis of KEGG pathway and scatter plot for DEGs. [(<bold>A</bold>,<bold>B</bold>)] KEGG pathway analysis of DEGs (<italic toggle="yes">p</italic> &#x0003c; 0.05 and |log2FC| &#x0003e; 1) in cells infected with ASFV CN/GS or ASFV-&#x00394;10L/&#x00394;7R at 12 h and 24 h. KEGG enrichment was measured by RichFactor, <italic toggle="yes">p</italic>-value, and the number of genes associated with each pathway. The color and size of the dots represent fold changes and the number of DEGs enriched in each pathway, respectively. [(<bold>C</bold>,<bold>D</bold>)] Scatter plot analysis of DEGs (<italic toggle="yes">p</italic> &#x0003c; 0.05 and |log2FC| &#x0003e; 1) in cells infected with ASFV CN/GS or ASFV-&#x00394;10L/&#x00394;7R at 12 h and 24 h. In the differential expression scatter plot, each dot represents a gene: green dots indicate downregulated DEGs, red dots indicate upregulated DEGs, grey dots represent genes with no significant difference, and the diagonal line represents genes with equal expression in both groups.</p></caption><graphic xlink:href="viruses-17-00283-g005" position="float"/></fig><fig position="float" id="viruses-17-00283-f006"><label>Figure 6</label><caption><p>Comparison of RNA-seq results between ASFV CN/GS and ASFV-&#x00394;10L/&#x00394;7R during infection. [(<bold>A</bold>,<bold>B</bold>)] Gene Ontology (GO) functional enrichment analysis of DEGs in cells infected with ASFV CN/GS or ASFV-&#x00394;10L/&#x00394;7R at 12 h and 24 h. [(<bold>C</bold>,<bold>D</bold>)] Heatmap of DEGs in cells infected with ASFV CN/GS or ASFV-&#x00394;10L/&#x00394;7R at 12 h and 24 h. A total of 30 DEGs related to innate immunity were selected and are displayed in the heatmap. The colors represent the fold changes (FCs) at the indicated time points.</p></caption><graphic xlink:href="viruses-17-00283-g006" position="float"/></fig><fig position="float" id="viruses-17-00283-f007"><label>Figure 7</label><caption><p>Expression levels of innate immune-related DEGs. (<bold>A</bold>) RNA-Seq analysis of the expression levels of <italic toggle="yes">CXCL10</italic>, <italic toggle="yes">ISG15</italic>, <italic toggle="yes">IFIT1</italic>, <italic toggle="yes">GBP1</italic>, and <italic toggle="yes">IFN-&#x003b2;</italic> genes in BMDMs infected with ASFV CN/GS or ASFV-&#x00394;10L/&#x00394;7R at 12 h and 24 h. (<bold>B</bold>) RT-qPCR analysis of the relative mRNA expression levels of <italic toggle="yes">CXCL10</italic>, <italic toggle="yes">ISG15</italic>, <italic toggle="yes">IFIT1</italic>, <italic toggle="yes">GBP1</italic>, and <italic toggle="yes">IFN-&#x003b2;</italic> genes in ASFV CN/GS- and ASFV-&#x00394;10L/&#x00394;7R-infected BMDMs (0.1 MOI) at 12 h and 24 h. [(<bold>A</bold>,<bold>B</bold>)] Data represent at least three independent experiments and are presented as mean &#x000b1; SEM of three biological replicates analyzed by two-way ANOVA. ns for <italic toggle="yes">p</italic> &#x0003e; 0.05, * <italic toggle="yes">p</italic> &#x0003c; 0.05, ** <italic toggle="yes">p</italic> &#x0003c; 0.01, *** <italic toggle="yes">p</italic> &#x0003c; 0.001, **** <italic toggle="yes">p</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="viruses-17-00283-g007" position="float"/></fig><table-wrap position="float" id="viruses-17-00283-t001"><object-id pub-id-type="pii">viruses-17-00283-t001_Table 1</object-id><label>Table 1</label><caption><p>List of primers and primer sequences.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Primer</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sequence</th></tr></thead><tbody><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">p72 (Taqman qPCR)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-ATGGAAATTCCCTAGACGAA-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-CACTGGTTCCCTCCACCGAT-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TaqMan probe</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-FAM-ACCTCCTGGCCAACCAAGTGCT-BHQ1-3&#x02019;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">p-IFIT1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-TCAGAGGTGAGAAGGCTGGT-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-GCTTCCTGCAAGTGTCCTTC-3&#x02019;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">p-ISG15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-GACTGCATGATGGCATCGGA-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-TGCACCATCAACAGGACCAT-3&#x02019;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">p-GBP1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-GAAGGGTGACAACCAGAACGAC-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-AGGTTCCGACTTTGCCCTGATT-3&#x02019;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">p-INF-&#x003b2;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-CACTGGCTGGAATGAAACCg-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-AATGGTCATGTCTCCCCTGG-3&#x02019;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">p-CXCL10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-CTGTTCGCTGTACCTGCATC-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-GCTTCTCTCTGTGTTCGAGG-3&#x02019;</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">p-GAPDH</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-ACATGGCCTCCAAGGAGTAAGA-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-GATCGAGTTGGGGCTGTGACT-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">505-7R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-TTTGGGAAAATCCCGCGGAAAGAA-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">505-7R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-TCCTGTAGGGAGAACATTTTCTCT-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">360-10L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-TAGGGCCTTTGCCTCTTCAAAGG-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">360-10L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-GGCTTGGACCTTAATACGGCAC-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B646L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-CCGGGGTATTCGCAGTAGTA-3&#x02019;</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B646L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#x02019;-ATCCCGAACCCACTTTGAGT-3&#x02019;</td></tr></tbody></table></table-wrap><table-wrap position="float" id="viruses-17-00283-t002"><object-id pub-id-type="pii">viruses-17-00283-t002_Table 2</object-id><label>Table 2</label><caption><p>Summary of mutations between ASFV-&#x00394;10L/&#x00394;7R and its parental strain.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mutation Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Start</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Alt.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Amino Acid Change</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SNV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79065</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">M1249L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asp455Gly</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SNV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">138786</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D205R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asn102Thr</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SNV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">167129</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E199L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gln104His</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SNV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">167188</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E199L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ala85Pro</td></tr></tbody></table></table-wrap></floats-group></article>